Kearney, NE. - SCORR Marketing, a global full-service marketing and communications firm, in partnership with Applied Clinical Trials, conducted a survey of clinical trial project managers to gain a better understanding of the level of company support they need and receive, the culture of their organizations and the biggest challenges they face in their jobs. “As the complexity of clinical trials increases, the demand for more proficient project managers increases as well,” said Cliff Echols, market intelligence director at SCORR. “The goal of this survey was to gain insight into the expectations and responsibilities of project managers that have been added as a result of the evolving nature of clinical trials.” The report details project managers’ current and desired levels of company support and training, and availability and importance of career development opportunities. It also reveals the most valuable skill sets for project managers to possess and their most challenging responsibilities. Survey respondents included program managers with varying levels of experience from international pharmaceutical companies, CROs, academic institutions, biotech companies and research sites. “Sponsors can use the results of this survey to make more insightful decisions and build stronger relationships with project management teams,” said Lisa Henderson, editor in chief at Applied Clinical Trials. About SCORR Marketing SCORR Marketing is the leading marketing and communications firm in the health sciences industry. We partner with organizations involved in global research, development and commercialization of biopharmaceutical and device products and the delivery of health care products and services. At SCORR, we achieve results for our clients by applying our proven, disciplined approach to synthesize market intelligence, strategy and creativity. We have locations across North America and Europe. For more information, visit www.scorrmarketing.com.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.